Issues related to coverage of and reimbursement for Human Cell & Tissue products, including Local Coverage Determination L39764- Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers; H.R.5768 Skin Substitute Access and Payment Reform Act; S.2561 Skin Substitute Access and Payment Reform Act; and H.R.6852 Advanced Wound Care and Regenerative Medicine Access
Literal federal measure citations: H.R.5768, S.2561, H.R.6852